Invivyd (IVVD) Gross Margin (2024 - 2026)
Invivyd's (IVVD) quarterly Gross Margin came in at 91.09% in Q2 2026, down 310.0% on a YoY basis from 43.38% in Q2 2025, and down 2.45% quarter-over-quarter from 93.37% in Q4 2025.
Analysis
Invivyd (IVVD) Gross Margin (2024 - 2026) Analysis & Trends
Invivyd (IVVD) has reported Gross Margin for 3 consecutive years, with 91.09% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Gross Margin fell 310.0% year-over-year to 91.09%; the trailing twelve-month figure through Jun 2026 stood at 92.58% (down 82.0% YoY), and the FY2025 full-year result was 92.99%, down 64.0% from the prior year.
- Gross Margin slipped to 91.09% in Q2 2026 per IVVD's latest filing, from 93.37% in the prior quarter.
- Across five years, Gross Margin topped out at 96.11% in Q2 2024 and bottomed at 91.09% in Q2 2026.
- Historically, Gross Margin has averaged 93.15% across 3 years, with a median of 93.0% in 2025.
- The sharpest annual moves came in 2025 and 2026: Gross Margin jumped 38 bps in 2025, then plunged 310 bps in 2026.
- Over 3 years, Gross Margin stood at 94.76% in 2024, then fell by 1 bps to 93.37% in 2025, then decreased by 2 bps to 91.09% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 91.09%, 93.37%, and 91.71% for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 72.04% |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 79.76% |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 85.33% |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 91.59% |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 90.43% |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 35.86% |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 76.90% |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 71.60% |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 84.20% |
| 10 | Invivyd | 244.65 Mn | 84.57 Mn | 13.01 Mn | 91.09% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 91.09% |
| Dec 31, 2025 | 93.37% |
| Sep 30, 2025 | 91.71% |
| Jun 30, 2025 | 94.19% |
| Mar 31, 2025 | 92.62% |
| Dec 31, 2024 | 94.76% |
| Sep 30, 2024 | 91.33% |
| Jun 30, 2024 | 96.11% |